Factsheet Interactions between HIV treatment and recreational drugs

Roger Pebody, Published November 2015

Key points

  • A drug interaction can affect the drugs’ effectiveness and side-effects.
  • The anti-HIV drugs ritonavir and cobicistat have the most interactions.
  • A frank discussion with your HIV doctor or HIV pharmacist is recommended.

When two drugs are taken at the same time, their interaction can affect the drugs’ effectiveness and side-effects.

This is the case both for prescribed medicines and recreational drugs, although there is much less medical research on drug interactions with illicit drugs. But we do know that some anti-HIV drugs and some recreational drugs are metabolised (processed) by the same pathways in the body. This can alter the effect of one or both drugs when they are combined.

This applies to some, but not all anti-HIV drugs. Similarly it only affects some recreational drugs.

Nonetheless, recreational drugs are rarely sold in a pure form, so it is hard to know what they contain. They may have been ‘cut’ with other substances and may contain larger or smaller quantities of the active ingredient than expected. Predicting how recreational drugs will interact with HIV medications is not straightforward.

Ritonavir and cobicistat

The two anti-HIV drugs most likely to be involved in harmful interactions with recreational drugs are ritonavir (Norvir) and cobicistat (Tybost).

Both of these are boosting agents, taken to boost levels of other antiretrovirals. Adding a small dose of one of these agents makes the liver break down the primary drug more slowly, so that it stays in the body for longer or at higher levels. Without the boosting agent, the prescribed dose of the primary drug would be ineffective.

The boosting mechanism can also affect recreational drugs. The liver processes the recreational drug more slowly, resulting in the recreational drug staying in the body for longer or in greater concentrations. Sometimes this can cause serious side-effects or an overdose.

"The interaction may increase the intensity of the effect of the recreational drug, sometimes to unpleasant or dangerous levels."

If your HIV treatment includes a protease inhibitor, you are probably taking either ritonavir (Norvir) or cobicistat (Tybost). Protease inhibitors include darunavir (Prezista), atazanavir (Reyataz) and lopinavir (Kaletra).

Cobicistat is also taken with the integrase inhibitor elvitegravir (Vitekta). It is included in the combination pills Stribild (with elvitegravir, tenofovir disoproxil and emtricitabine), Rezolsta (with darunavir) and Evotaz (with atazanavir).

Ritonavir is also in a combination pill used to treat hepatitis C called Viekirax (with ombitasvir and pariteprevir).

If you are not sure which medications you are taking, staff at your HIV clinic can tell you.

Recreational drugs of concern

A dangerous interaction is possible between ritonavir or cobicistat and several recreational drugs:

  • Crystal methamphetamine (crystal, tina, meth)
  • MDMA (ecstasy, X, mandy)
  • Mephedrone (miaw miaw, plant food, bath salts)
  • Ketamine (K, vitamin K, special K)
  • Erectile dysfunction drugs (Viagra, Cialis, Levitra)
  • Benzodiazepines (benzos, Valium, Xanax)

The interaction may increase the intensity of the effect of the recreational drug, sometimes to unpleasant or dangerous levels.

Experts judge the potential for interactions with the first three drugs listed to be ‘moderate’ and with the last three to be ‘high’. There have been a handful of documented cases of deaths and serious side-effects in people taking ritonavir alongside crystal meth, MDMA or ketamine.

Heavy use of ketamine can lead to damage to the liver and bile ducts. Overdoses of erectile dysfunction drugs are dangerous for the heart. An overdose of benzodiazepines could result in the person passing out.

Poppers may also interact with erectile dysfunction drugs, causing a potentially dangerous drop in blood pressure. This may be more likely if you are also taking ritonavir or cobicistat.

For GHB (gamma-hydroxybutyrate) and GBL (gamma-butyrolactone), the risk of interactions is unknown.

Non-nucleoside reverse transcriptase inhibitors

Concerning non-nucleoside reverse transcriptase inhibitors (NNRTIs), a different type of interaction is expected as these drugs are metabolised in a different way. The interaction may result in levels of the recreational drug being lower than would normally be expected.

This applies specifically to efavirenz (Sustiva, also a component of Atripla), nevirapine (Viramune) and etravirine (Intelence). In contrast rilpivirine (Edurant) is not thought to interact with recreational drugs.

The interaction may occur with cocaine, ketamine and erectile dysfunction drugs.

Drugs without significant interactions

The potential for interactions with several other substances is considered to be low. This includes alcohol, cannabis, poppers, heroin and other opioids.

Similarly, several antiretroviral drugs are not thought to have problems with interactions. These include:

  • All nucleoside reverse transcriptase inhibitors (NRTIs)
  • Rilpivirine (Edurant), a non-nucleoside reverse transcriptase inhibitor (NNRTI)
  • Raltegravir (Isentress) and dolutegravir (Tivicay), both integrase inhibitors
  • Maraviroc (Celsentri), a CCR5 inhibitor

The University of Liverpool’s HIV Drug Interactions website (www.hiv-druginteractions.org) publishes a table summarising the likely interactions.

Practical advice

The first four weeks of taking a new HIV treatment combination, when your body gets used to the new drugs, are likely to be the riskiest time for interactions.

A frank discussion with your HIV doctor or HIV pharmacist can give you a better understanding of the risks, based on your own situation. If you don’t want to stop or can’t stop using recreational drugs, switching to an HIV treatment with less potential for interactions might be an option.

Recreational drugs have a wide range of impacts on physical and mental health, both in the short and long term. You can find more detailed information on their effects and legal status on the FRANK website (www.talktofrank.com).

Drug use can interfere with sleeping patterns and routines, making missed doses of your HIV treatment more likely.

In sexual situations, drug use can affect your judgement about what is safe or appropriate. You may be more likely to put yourself or others at risk of hepatitis C, HIV or other sexually transmitted infections.

If you inject drugs, it’s important not to share or re-use equipment with others (including water, swabs, filters, spoons and tourniquets).


If you are concerned about your drug use, there’s information and support available. You could start by talking to staff at your HIV clinic. You can also look for local services on the FRANK website. In London, specialised services are available at the 56 Dean Street clinic and (for LGBT people) the Antidote drugs and alcohol service.

This factsheet is due for review in November 2018

Find out more

Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.